These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10901336)

  • 1. Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.
    Fredman SJ; Fava M; Kienke AS; White CN; Nierenberg AA; Rosenbaum JF
    J Clin Psychiatry; 2000 Jun; 61(6):403-8. PubMed ID: 10901336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of nonresponse and intolerance: switching strategies.
    Fava M
    J Clin Psychiatry; 2000; 61 Suppl 2():10-2. PubMed ID: 10714618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
    Hirschfeld RM; Montgomery SA; Aguglia E; Amore M; Delgado PL; Gastpar M; Hawley C; Kasper S; Linden M; Massana J; Mendlewicz J; Möller HJ; Nemeroff CB; Saiz J; Such P; Torta R; Versiani M
    J Clin Psychiatry; 2002 Sep; 63(9):826-37. PubMed ID: 12363125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociological influences on antidepressant prescribing.
    Sleath B; Shih YC
    Soc Sci Med; 2003 Mar; 56(6):1335-44. PubMed ID: 12600369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.
    Mischoulon D; Nierenberg AA; Kizilbash L; Rosenbaum JF; Fava M
    Can J Psychiatry; 2000 Jun; 45(5):476-81. PubMed ID: 10900529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antidepressant combinations: which, when and why? Results of a Spanish survey.
    de la Gándara J; Agüera L; Rojo JE; Ros S; de Pedro JM
    Acta Psychiatr Scand Suppl; 2005; (428):32-6. PubMed ID: 16307618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of prescribing preferences in the treatment of refractory depression: recent trends.
    Kornbluh R; Papakostas GI; Petersen T; Neault NB; Nierenberg AA; Rosenbaum JF; Fava M
    Psychopharmacol Bull; 2001; 35(3):150-6. PubMed ID: 12397884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A; de Filippis R; Proietti L
    World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
    Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.
    Gonul AS; Akdeniz F; Donat O; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):889-91. PubMed ID: 12921926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters.
    Sclar DA; Robison LM; Skaer TL; Galin RS
    Int J Psychiatry Med; 1998; 28(4):407-19. PubMed ID: 10207740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing practices in the treatment of depression among psychiatrists in Oman.
    Albalushi MA; Almaqbali MH; Al-Huseini SK; Alsinawi HN
    Neurosciences (Riyadh); 2021 Apr; 26(2):152-157. PubMed ID: 33814367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to an open trial of a second SSRI in major depression.
    Joffe RT; Levitt AJ; Sokolov ST; Young LT
    J Clin Psychiatry; 1996 Mar; 57(3):114-5. PubMed ID: 8617695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled long-term prevention of unipolar depression with antidepressive agents of the second generation (SSRI)].
    Zimmermann U
    Psychiatr Prax; 1996 Sep; 23(5):240-3. PubMed ID: 8992518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting.
    Kern DM; Cepeda MS; Castilla-Puentes RC; Savitz A; Etropolski M
    Curr Med Res Opin; 2021 Aug; 37(8):1377-1384. PubMed ID: 33818238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and outcomes for patients with depression who are partial responders to SSRI treatment: post-hoc analysis findings from the FINDER European observational study.
    Lenox-Smith A; Martinez JM; Perahia D; Dowsett SA; Dennehy EB; Lopez-Romero P; Demyttenaere K
    J Affect Disord; 2014 Dec; 169():149-56. PubMed ID: 25194783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.